Found 0 matching trials
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma PHASE2 This pilot phase II trial studies how well giving brentuximab vedotin, comb...
Show More Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Learn More & Join Trial
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma PHASE1 The purpose of this study is to assess the safety profile of brentuximab ve...
Show More Learn More & Join Trial
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma PHASE1 This phase I/II trial studies the side effects and best dose of ceritinib w...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma PHASE2 This is an open-label, multicenter, phase 2 clinical trial to evaluate the ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease. PHASE2 This is a single-arm, open-label, multicenter, clinical trial to evaluate t...
Show More Location
ASST Spedali Civili di Brescia
Learn More & Join Trial
Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients PHASE1 The purpose of this study is to evaluate the safety and effectiveness of TG...
Show More Location
TG Therapeutics Investigational Trial Site
Learn More & Join Trial
Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma PHASE2 This is a randomized, open-label, multicenter, Phase 2 clinical trial desig...
Show More Learn More & Join Trial
A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL PHASE2 Study Objectives Primary:
⢠To determine the antitumor efficacy of single-...
Show More Location
S.C. Ematologia A.O. SS. Antonio e Biagio e C. Arrigo
Learn More & Join Trial
Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas PHASE2 For participants with CD30 positive Mature T-cell lymphomas who have receiv...
Show More Location
The University of Kansas Cancer Center, Westwood Campus
Learn More & Join Trial
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL PHASE2 Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/...
Show More Location
New York Medical College
Learn More & Join Trial